Profile
Eric Feldman formerly worked at Seagen Inc., as Senior Medical Director from 2014 to 2017, NewYork-Presbyterian Hospital, as Director-Hematological Malignancies Service, GlycoMimetics, Inc., as Vice President-Clinical Development from 2019 to 2021, and Amphivena Therapeutics, Inc., as Chief Medical Officer from 2018 to 2019.
Dr. Feldman received his undergraduate degree from Tulane University (Louisiana) and undergraduate degree from New York Medical College.
Former positions of Eric Feldman
| Companies | Position | End |
|---|---|---|
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Corporate Officer/Principal | 2019-03-31 |
| SEAGEN INC. | Chief Tech/Sci/R&D Officer | 2017-11-30 |
NewYork-Presbyterian Hospital
NewYork-Presbyterian Hospital Miscellaneous Commercial ServicesCommercial Services Owns and operates hospitals and that provides medical care & telemedicine services | Corporate Officer/Principal | - |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Chief Tech/Sci/R&D Officer | - |
Training of Eric Feldman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
NewYork-Presbyterian Hospital
NewYork-Presbyterian Hospital Miscellaneous Commercial ServicesCommercial Services Owns and operates hospitals and that provides medical care & telemedicine services | Commercial Services |
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
New York Medical College
New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Health Technology |
- Stock Market
- Insiders
- Eric Feldman
















